additional

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

4 months ago

EquiLend’s 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow

A major step toward unified trade reconciliation across securities finance NEW YORK, Oct. 15, 2025 /PRNewswire/ -- EquiLend, the global…

4 months ago

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million

SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

5 months ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund…

5 months ago

Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date

August 28, 2025 17:55 ET  | Source: Enovix Corporation Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025…

6 months ago

MANTRA Announces Additional $25,000,000 Minimum Funding Commitment for First of Strategic OM Token Buybacks

Backed by key investors and stakeholders the buyback will be executed transparently over several months across publicly traded centralized exchange…

6 months ago

Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares

August 22, 2025 12:00 ET  | Source: Invivyd WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq:…

6 months ago

Abivax Announces Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) PARIS,…

7 months ago

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

July 24, 2025 07:00 ET  | Source: TCG Labs Soleil SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- TCG Labs…

7 months ago

Tulip Innovation Obtains Additional Battery Patent Injunction against Sunwoda Group

BUDAPEST, Hungary, July 23, 2025 /PRNewswire/ -- On 17 July 2025, Tulip Innovation won another injunction in German litigation concerning…

7 months ago